Intersection of AHR and Wnt signaling in development, health, and disease

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 17852-17885

  Schneider, Andrew J ^a   Branam, Amanda M ^a   Peterson, Richard E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

AHR (aryl hydrocarbon receptor); Development; Disease; Prostate; TCDD (2, 3, 7, 8 tetrachlorodibenzo p dioxin); Toxicity; Wnt (wingless related MMTV integration site); catenin (CTNNB1)

Indexed keywords

2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BETA CATENIN; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN 90; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; MYC PROTEIN; ORPHAN NUCLEAR RECEPTOR; PROTEIN P23; UNCLASSIFIED DRUG; WNT PROTEIN; WNT5A PROTEIN; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

DEVELOPMENTAL BIOLOGY; DISEASES; EMBRYO DEVELOPMENT; ENZYME INDUCTION; GENE EXPRESSION; HEALTH SCIENCE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; PROSTATE;

MOUSE MAMMARY TUMOR VIRUS;

ANIMALS; BETA CATENIN; EMBRYONIC DEVELOPMENT; HUMANS; MALE; PROSTATE; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; WNT PROTEINS;

EID: 84907829576     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151017852     Document Type: Review

References (190)

1. Hahn, M. E. Aryl hydrocarbon receptors: Diversity and evolution. Chem. Biol. Interact. 2002, 141, 131-160.
2. McMillan, B. J.; Bradfield, C. A. The aryl hydrocarbon receptor sans xenobiotics: Endogenous function in genetic model systems. Mol. Pharmacol. 2007, 72, 487-498.
3. Nusse, R. Wnt signaling in disease and in development. Cell Res. 2005, 15, 28-32.
4. Lebreton, G.; Faucher, C.; Cribbs, D. L.; Benassayag, C. Timing of wingless signalling distinguishes maxillary and antennal identities in drosophila melanogaster. Development 2008, 135, 2301-2309.
5. Song, S.; Zhang, B.; Sun, H.; Li, X.; Xiang, Y.; Liu, Z.; Huang, X.; Ding, M. A Wnt-Frz/Ror-Dsh pathway regulates neurite outgrowth in Caenorhabditis elegans. PLoS Genet. 2010, 6, e1001056.
6. Zhang, J.; Li, X.; Jevince, A. R.; Guan, L.; Wang, J.; Hall, D. H.; Huang, X.; Ding, M. Neuronal target identification requires aha-1-mediated fine-tuning of wnt signaling in C. Elegans. PLoS Genet. 2013, 9, e1003618.
7. Van Amerongen, R.; Berns, A. Knockout mouse models to study wnt signal transduction. Trends Genet. 2006, 22, 678-689.
8. Grigoryan, T.; Wend, P.; Klaus, A.; Birchmeier, W. Deciphering the function of canonical wnt signals in development and disease: Conditional loss-and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008, 22, 2308-2341.
9. Rudloff, S.; Kemler, R. Differential requirements for β-catenin during mouse development. Development 2012, 139, 3711-3721.
10. Goodale, B. C.; la Du, J. K.; Bisson, W. H.; Janszen, D. B.; Waters, K. M.; Tanguay, R. L. AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafish. PloS One 2012, 7, e29346.
11. Harrill, J. A.; Hukkanen, R. R.; Lawson, M.; Martin, G.; Gilger, B.; Soldatow, V.; Lecluyse, E. L.; Budinsky, R. A.; Rowlands, J. C.; Thomas, R. S. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice. Toxicol. Appl. Pharmacol. 2013, 272, 503-518.
12. Barouki, R.; Coumoul, X.; Fernandez-Salguero, P. M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 2007, 581, 3608-3615.
13. Abel, J.; Haarmann-Stemmann, T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 2010, 391, 1235-1248.
14. Nguyen, L. P.; Bradfield, C. A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 2008, 21, 102-116.
15. Couture, L. A.; Abbott, B. D.; Birnbaum, L. S. A critical review of the developmental toxicity and teratogenicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 1990, 42, 619-627.
16. Dobrzyński, M.; Całkosiński, I.; Przywitowska, I.; Kobierska-Brzoza, J.; Czajczyńska-Waszkiewicz, A.; Sołtan, E.; Parulska, O. Effects of dioxins in environmental pollution on development of tooth disorders. Pol. J. Environ. Stud. 2009, 18, 319-323.
17. Vezina, C. M.; Lin, T. M.; Peterson, R. E. AHR signaling in prostate growth, morphogenesis, and disease. Biochem. Pharmacolo. 2009, 77, 566-576.
18. Kransler, K. M.; McGarrigle, B. P.; Swartz, D. D.; Olson, J. R. Lung development in the holtzman rat is adversely affected by gestational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2009, 107, 498-511.
19. Yoshioka, W.; Peterson, R. E.; Tohyama, C. Molecular targets that link dioxin exposure to toxicity phenotypes. J. Steroid Biochem. Mol. Biol. 2011, 127, 96-101.
20. King-Heiden, T. C.; Mehta, V.; Xiong, K. M.; Lanham, K. A.; Antkiewicz, D. S.; Ganser, A.; Heideman, W.; Peterson, R. E. Reproductive and developmental toxicity of dioxin in fish. Mol. Cell. Endocrinol. 2012, 354, 121-138.
21. Plavicki, J.; Hofsteen, P.; Peterson, R. E.; Heideman, W. Dioxin inhibits zebrafish epicardium and proepicardium development. Toxicol. Sci. 2013, 131, 558-567.
22. Baker, T. R.; Peterson, R. E.; Heideman, W. Early dioxin exposure causes toxic effects in adult zebrafish. Toxicol. Sci. 2013, 135, 241-250.
23. Polakis, P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 2012, 4, a008052.
24. Dietrich, C.; Kaina, B. The aryl hydrocarbon receptor (AHR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 2010, 31, 1319-1328.
25. Feng, S.; Cao, Z.; Wang, X. Role of aryl hydrocarbon receptor in cancer. Biochim. Biophys. Acta 2013, 1836, 197-210.
26. Safe, S.; Lee, S. O.; Jin, U. H. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol. Sci. 2013, 135, 1-16.
27. Dashwood, R. H. Indole-3-carbinol: Anticarcinogen or tumor promoter in brassica vegetables? Chem. Biol. Interact. 1998, 110, 1-5.
28. min/+ mice with natural ligands. Proc. Natl. Acad. Sci. USA 2009, 106, 13481-13486.
29. Fritz, W. A.; Lin, T. M.; Cardiff, R. D.; Peterson, R. E. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in tramp mice. Carcinogenesis 2007, 28, 497-505.
30. Fan, Y.; Boivin, G. P.; Knudsen, E. S.; Nebert, D. W.; Xia, Y.; Puga, A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res. 2010, 70, 212-220.
31. Hall, J. M.; Barhoover, M. A.; Kazmin, D.; McDonnell, D. P.; Greenlee, W. F.; Thomas, R. S. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol. Endocrinol. 2010, 24, 359-369.
32. O'Donnell, E. F.; Koch, D. C.; Bisson, W. H.; Jang, H. S.; Kolluri, S. K. The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells. Cell Death Dis. 2014, 5, e1038.
33. Yamamoto, J.; Ihara, K.; Nakayama, H.; Hikino, S.; Satoh, K.; Kubo, N.; Iida, T.; Fujii, Y.; Hara, T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: Organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci. 2004, 74, 1039-1049.
34. Jain, S.; Maltepe, E.; Lu, M. M.; Simon, C.; Bradfield, C. A. Expression of ARNT, ARNT2, HIF1α, HIF2α and Ah receptor mRNAs in the developing mouse. Mech. Dev. 1998, 73, 117-123.
35. Jiang, Y. Z.; Wang, K.; Fang, R.; Zheng, J. Expression of aryl hydrocarbon receptor in human placentas and fetal tissues. J. Histochem. Cytochem. 2010, 58, 679-685.
36. Diez-Roux, G.; Banfi, S.; Sultan, M.; Geffers, L.; Anand, S.; Rozado, D.; Magen, A.; Canidio, E.; Pagani, M.; Peluso, I.; et al. A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol. 2011, 9, e1000582.
37. Andreasen, E. A.; Spitsbergen, J. M.; Tanguay, R. L.; Stegeman, J. J.; Heideman, W.; Peterson, R. E. Tissue-specific expression of AHR2, ARNT2, and CYP1A in zebrafish embryos and larvae: Effects of developmental stage and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin exposure. Toxicol. Sci. 2002, 68, 403-419.
38. Stevens, E. A.; Mezrich, J. D.; Bradfield, C. A. The aryl hydrocarbon receptor: A perspective on potential roles in the immune system. Immunology 2009, 127, 299-311.
39. Denison, M. S.; Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 309-334.
40. Bjeldanes, L. F.; Kim, J. Y.; Grose, K. R.; Bartholomew, J. C.; Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA 1991, 88, 9543-9547.
41. Hrubá, E.; Vondráček, J.; Líbalová, H.; Topinka, J.; Bryja, V.; Souček, K.; Machala, M. Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands. Toxicol. Lett. 2011, 206, 178-188.
42. Li, Y.; Li, X.; Sarkar, F. H. Gene expression profiles of I3C-and DIM-treated PC3 human prostate cancer cells determined by cdna microarray analysis. J. Nutr. 2003, 133, 1011-1019.
43. Adachi, J.; Mori, Y.; Matsui, S.; Matsuda, T. Comparison of gene expression patterns between 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol. Sci. 2004, 80, 161-169.
44. Mathew, L. K.; Sengupta, S. S.; Ladu, J.; Andreasen, E. A.; Tanguay, R. L. Crosstalk between AHR and Wnt signaling through R-spondin1 impairs tissue regeneration in zebrafish. FASEB J. 2008, 22, 3087-3096.
45. Arima, A.; Kato, H.; Ise, R.; Ooshima, Y.; Inoue, A.; Muneoka, A.; Kamimura, S.; Fukusato, T.; Kubota, S.; Sumida, H.; et al. In utero and lactational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) induces disruption of glands of the prostate and fibrosis in rhesus monkeys. Reprod. Toxicol. 2010, 29, 317-322.
46. Hao, N.; Lee, K. L.; Furness, S. G.; Bosdotter, C.; Poellinger, L.; Whitelaw, M. L. Xenobiotics and loss of cell adhesion drive distinct transcriptional outcomes by aryl hydrocarbon receptor signaling. Mol. Pharmacol. 2012, 82, 1082-1093.
47. Faust, D.; Vondráček, J.; Krčmář, P.; Šmerdová, L.; Procházková, J.; Hrubá, E.; Hulinková, P.; Kaina, B.; Dietrich, C.; Machala, M. AHR-mediated changes in global gene expression in rat liver progenitor cells. Arch. Toxicol. 2013, 87, 681-698.
48. Moriguchi, T.; Motohashi, H.; Hosoya, T.; Nakajima, O.; Takahashi, S.; Ohsako, S.; Aoki, Y.; Nishimura, N.; Tohyama, C.; Fujii-Kuriyama, Y.; et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. USA 2003, 100, 5652-5657.
49. Silkworth, J. B.; Koganti, A.; Illouz, K.; Possolo, A.; Zhao, M.; Hamilton, S. B. Comparison of TCDD and PCB CYP1A induction sensitivities in fresh hepatocytes from human donors, sprague-dawley rats, and rhesus monkeys and HepG2 cells. Toxicol. Sci. 2005, 87, 508-519.
50. Boutros, P. C.; Yan, R.; Moffat, I. D.; Pohjanvirta, R.; Okey, A. B. Transcriptomic responses to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: Comparison of rat and mouse. BMC Genomics 2008, 9, 419.
51. Budinsky, R. A.; LeCluyse, E. L.; Ferguson, S. S.; Rowlands, J. C.; Simon, T. Human and rat primary hepatocyte cyp1a1 and 1a2 induction with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, 2, 3, 7, 8-tetrachlorodibenzofuran, and 2, 3, 4, 7, 8-pentachlorodibenzofuran. Toxicol. Sci. Toxicol. 2010, 118, 224-235.
52. Hockley, S. L.; Arlt, V. M.; Brewer, D.; Te Poele, R.; Workman, P.; Giddings, I.; Phillips, D. H. AHR-and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem. Res. Toxicol. 2007, 20, 1797-1810.
53. Boutros, P. C.; Bielefeld, K. A.; Pohjanvirta, R.; Harper, P. A. Dioxin-dependent and dioxin-independent gene batteries: Comparison of liver and kidney in AHR-null mice. Toxicol. Sci. 2009, 112, 245-256.
54. Vezina, C. M.; Walker, N. J.; Olson, J. R. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: Effect on hepatic gene expression. Environ. Health Perspect. 2004, 112, 1636-1644.
55. Moffat, I. D.; Boutros, P. C.; Chen, H.; Okey, A. B.; Pohjanvirta, R. Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 2010, 11, 263.
56. Boutros, P. C.; Yao, C. Q.; Watson, J. D.; Wu, A. H.; Moffat, I. D.; Prokopec, S. D.; Smith, A. B.; Okey, A. B.; Pohjanvirta, R. Hepatic transcriptomic responses to tcdd in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity. Toxicol. Appl. Pharmacol. 2011, 251, 119-129.
57. Kerley-Hamilton, J. S.; Trask, H. W.; Ridley, C. J.; Dufour, E.; Lesseur, C.; Ringelberg, C. S.; Moodie, K. L.; Shipman, S. L.; Korc, M.; Gui, J.; et al. Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in mice. Toxicol. Sci. 2012, 126, 391-404.
58. Ohtake, F.; Baba, A.; Takada, I.; Okada, M.; Iwasaki, K.; Miki, H.; Takahashi, S.; Kouzmenko, A.; Nohara, K.; Chiba, T.; et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007, 446, 562-566.
59. Niehrs, C. The complex world of wnt receptor signalling. Nat. Rev. Mol. Cell Biol. 2012, 13, 767-779.
60. Ueno, K.; Hirata, H.; Hinoda, Y.; Dahiya, R. Frizzled homolog proteins, micrornas and Wnt signaling in cancer. Int. J. Cancer. J. Int. Cancer 2013, 132, 1731-1740.
61. He, X.; Semenov, M.; Tamai, K.; Zeng, X. LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: Arrows point the way. Development 2004, 131, 1663-1677.
62. Carmon, K. S.; Lin, Q.; Gong, X.; Thomas, A.; Liu, Q. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/β-catenin signaling. Mol. Cell. Biol. 2012, 32, 2054-2064.
63. Minami, Y.; Oishi, I.; Endo, M.; Nishita, M. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases. Dev. Dyn. 2010, 239, 1-15.
64. Kikuchi, A.; Yamamoto, H.; Sato, A. Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol. 2009, 19, 119-129.
65. Grumolato, L.; Liu, G.; Mong, P.; Mudbhary, R.; Biswas, R.; Arroyave, R.; Vijayakumar, S.; Economides, A. N.; Aaronson, S. A. Canonical and noncanonical wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010, 24, 2517-2530.
66. Simons, B. W.; Hurley, P. J.; Huang, Z.; Ross, A. E.; Miller, R.; Marchionni, L.; Berman, D. M.; Schaeffer, E. M. Wnt signaling though β-catenin is required for prostate lineage specification. Dev. Biol. 2012, 371, 246-255.
67. Heuberger, J.; Birchmeier, W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol. 2010, 2, a002915.
68. Valenta, T.; Hausmann, G.; Basler, K. The many faces and functions of β-catenin. EMBO J. 2012, 31, 2714-2736.
69. Kimelman, D.; Xu, W. β-catenin destruction complex: Insights and questions from a structural perspective. Oncogene 2006, 25, 7482-7491.
70. MacDonald, B. T.; Tamai, K.; He, X. Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev. Cell 2009, 17, 9-26.
71. Li, V. S.; Ng, S. S.; Boersema, P. J.; Low, T. Y.; Karthaus, W. R.; Gerlach, J. P.; Mohammed, S.; Heck, A. J.; Maurice, M. M.; Mahmoudi, T.; et al. Wnt signaling through inhibition of β-catenin degradation in an intact axin1 complex. Cell 2012, 149, 1245-1256.
72. Stamos, J. L.; Weis, W. I. The β-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 2013, 5, a007898.
73. Jho, E. H.; Zhang, T.; Domon, C.; Joo, C. K.; Freund, J. N.; Costantini, F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22, 1172-1183.
74. Filali, M.; Cheng, N.; Abbott, D.; Leontiev, V.; Engelhardt, J. F. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem. 2002, 277, 33398-33410.
75. Driskell, R. R.; Goodheart, M.; Neff, T.; Liu, X.; Luo, M.; Moothart, C.; Sigmund, C. D.; Hosokawa, R.; Chai, Y.; Engelhardt, J. F. Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. Dev. Biol. 2007, 305, 90-102.
76. He, T. Identification of c-MYC as a target of the apc pathway. Science 1998, 281, 1509-1512.
77. Shukla, S.; MacLennan, G. T.; Flask, C. A.; Fu, P.; Mishra, A.; Resnick, M. I.; Gupta, S. Blockade of β-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res. 2007, 67, 6925-6935.
78. Reiners, J. J., Jr.; Clift, R.; Mathieu, P. Suppression of cell cycle progression by flavonoids: Dependence on the aryl hydrocarbon receptor. Carcinogenesis 1999, 20, 1561-1566.
79. Pillai, M. C.; Vines, C. A.; Wikramanayake, A. H.; Cherr, G. N. Polycyclic aromatic hydrocarbons disrupt axial development in sea urchin embryos through a β-catenin dependent pathway. Toxicology 2003, 186, 93-108.
80. Fairbairn, E. A.; Bonthius, J.; Cherr, G. N. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos. Aquat. Toxicol. 2012, 124-125, 188-196.
81. Tarapore, R. S.; Siddiqui, I. A.; Mukhtar, H. Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis 2012, 33, 483-491.
82. Jeong, Y.-M.; Li, H.; Kim, S. Y.; Yun, H.-Y.; Baek, K. J.; Kwon, N. S.; Myung, S. C.; Kim, D.-S. Indole-3-carbinol inhibits prostate cancer cell migration via degradation of β-catenin. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 2011, 19, 237-243.
83. Jellinck, P. H.; Forkert, P. G.; Riddick, D. S.; Okey, A. B.; Michnovicz, J. J.; Bradlow, H. L. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol. 1993, 45, 1129-1136.
84. Bradfield, C. A.; Bjeldanes, L. F. Structure-activity relationships of dietary indoles: A proposed mechanism of action as modifiers of xenobiotic metabolism. J. Toxicol. Environ. Health 1987, 21, 311-323.
85. Park, J. Y.; Bjeldanes, L. F. Organ-selective induction of cytochrome p-450-dependent activities by indole-3-carbinol-derived products: Influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat. Chem. Biol. Interact. 1992, 83, 235-247.
86. Takahashi, N.; Dashwood, R. H.; Bjeldanes, L. F.; Bailey, G. S.; Williams, D. E. Regulation of hepatic cytochrome p4501a by indole-3-carbinol: Transient induction with continuous feeding in rainbow trout. Food Chem. Toxicol. 1995, 33, 111-120.
87. Chen, I.; Safe, S.; Bjeldanes, L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol. 1996, 51, 1069-1076.
88. Guengerich, P. F.; Martin, M. V.; McCormick, W. A.; Nguyen, L. P.; Glover, E.; Bradfield, C. A. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch. Biochem. Biophys. 2004, 423, 309-316.
89. Leclerc, S.; Garnier, M.; Hoessel, R.; Marko, D.; Bibb, J. A.; Snyder, G. L.; Greengard, P.; Biernat, J.; Wu, Y. Z.; Mandelkow, E. M.; et al. Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 2001, 276, 251-260.
90. Choi, O. M.; Cho, Y. H.; Choi, S.; Lee, S. H.; Seo, S. H.; Kim, H. Y.; Han, G.; Min, D. S.; Park, T.; Choi, K. Y. The small molecule indirubin-3'-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity. Int. J. Obes. 2014, 38, 1044-1052.
91. Zahoor, M.; Cha, P. H.; Choi, K. Y. Indirubin-3'-oxime, an activator of Wnt/β-catenin signaling, enhances osteogenic commitment of ST2 cells and restores bone loss in high-fat diet-induced obese male mice. Bone 2014, 65, 60-68.
92. Daugherty, R. L.; Gottardi, C. J. Phospho-regulation of β-catenin adhesion and signaling functions. Physiology 2007, 22, 303-309.
93. Gao, C.; Xiao, G.; Hu, J. Regulation of Wnt/β-catenin signaling by posttranslational modifications. Cell Biosci. 2014, 4, 13: 1-13: 20.
94. Li, Y.; Wang, Z.; Kong, D.; Murthy, S.; Dou, Q. P.; Sheng, S.; Reddy, G. P.; Sarkar, F. H. Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3, 3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J. Biol. Chem. 2007, 282, 21542-21550.
95. Chang, C. C.; Lee, P. S.; Chou, Y.; Hwang, L. L.; Juan, S. H. Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: The therapeutic potential of statins. Am. J. Pathol. 2012, 181, 211-221.
96. Xu, G.; Li, Y.; Yoshimoto, K.; Wu, Q.; Chen, G.; Iwata, T.; Mizusawa, N.; Wan, C.; Nie, X. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway. Toxicol. Lett. 2014, 224, 362-370.
97. Chesire, D. R.; Dunn, T. A.; Ewing, C. M.; Luo, J.; Isaacs, W. B. Identification of aryl hydrocarbon receptor as a putative Wnt/β-catenin pathway target gene in prostate cancer cells. Cancer Res. 2004, 64, 2523-2533.
98. Jackson, A.; Vayssiere, B.; Garcia, T.; Newell, W.; Baron, R.; Roman-Roman, S.; Rawadi, G. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 2005, 36, 585-598.
99. Braeuning, A.; Kohle, C.; Buchmann, A.; Schwarz, M. Coordinate regulation of cytochrome P450 1A1 expression in mouse liver by the aryl hydrocarbon receptor and the β-catenin pathway. Toxicol. Sci. 2011, 122, 16-25.
100. Procházkova, J.; Kabátkova, M.; Bryja, V.; Umannová, L.; Bernatík, O.; Kozubík, A.; Machala, M.; Vondráček, J. The interplay of the aryl hydrocarbon receptor and β-catenin alters both AHR-dependent transcription and Wnt/β-catenin signaling in liver progenitors. Toxicol. Sci. 2011, 122, 349-360.
101. Baljinnyam, B.; Klauzinska, M.; Saffo, S.; Callahan, R.; Rubin, J. S. Recombinant R-spondin2 and Wnt3a Up-and Down-Regulate Novel Target Genes in C57MG Mouse Mammary Epithelial Cells. PLoS One 2012, 7, e29455.
102. Hailfinger, S.; Jaworski, M.; Braeuning, A.; Buchmann, A.; Schwarz, M. Zonal gene expression in murine liver: Lessons from tumors. Hepatology 2006, 43, 407-414.
103. Colnot, S.; Perret, C. Liver zonation. In Molecular Pathology of Liver Diseases; Monga, S. P. S., Ed.; Springer:, New York, USA, 2011; Volume 5, pp. 7-16.
104. Benhamouche, S.; Decaens, T.; Godard, C.; Chambrey, R.; Rickman, D. S.; Moinard, C.; Vasseur-Cognet, M.; Kuo, C. J.; Kahn, A.; Perret, C.; et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev. Cell 2006, 10, 759-770.
105. Braeuning, A.; Sanna, R.; Huelsken, J.; Schwarz, M. Inducibility of Drug-Metabolizing Enzymes by Xenobiotics in Mice with Liver-Specific Knockout of Ctnnb1. Drug Metab. Dispos. 2009, 37, 1138-1145.
106. Lindros, K. O.; Oinonen, T.; Johansson, I.; Ingelman-Sundberg, M. Selective centrilobular expression of the aryl hydrocarbon receptor in rat liver. J. Pharmacol. Exp. Ther. 1997, 280, 506-511.
107. Braeuning, A.; Ittrich, C.; Kohle, C.; Hailfinger, S.; Bonin, M.; Buchmann, A.; Schwarz, M. Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J. 2006, 273, 5051-5061.
108. Braeuning, A. Interplay of β-Catenin with Xenobiotic-Sensing Receptors and Its Role in Glutathione S-Transferase Expression. Curr. Drug Metab. 2012, 13, 203-214.
109. Stahl, S.; Ittrich, C.; Marx-Stoelting, P.; Kohle, C.; Altug-Teber, O.; Riess, O.; Bonin, M.; Jobst, J.; Kaiser, S.; Buchmann, A.; et al. Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology 2005, 42, 353-361.
110. Loeppen, S.; Koehle, C.; Buchmann, A.; Schwarz, M. A β-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis 2005, 26, 239-248.
111. Kim, K. A.; Zhao, J.; Andarmani, S.; Kakitani, M.; Oshima, T.; Binnerts, M. E.; Abo, A.; Tomizuka, K.; Funk, W. D. R-spondin proteins: A novel link to β-catenin activation. Cell Cycle 2006, 5, 23-26.
112. Nam, J. S.; Turcotte, T. J.; Smith, P. F.; Choi, S.; Yoon, J. K. Mouse Cristin/R-spondin Family Proteins Are Novel Ligands for the Frizzled 8 and LRP6 Receptors and Activate β-Catenin-dependent Gene Expression. J. Biol. Chem. 2006, 281, 13247-13257.
113. Wei, Q.; Yokota, C.; Semenov, M. V.; Doble, B.; Woodgett, J.; He, X. R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and β-catenin signaling. J. Biol. Chem. 2007, 282, 15903-15911.
114. Binnerts, M. E.; Kim, K. A.; Bright, J. M.; Patel, S. M.; Tran, K.; Zhou, M.; Leung, J. M.; Liu, Y.; Lomas, W. E., 3rd; Dixon, M.; et al. R-spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc. Natl. Acad. Sci. USA 2007, 104, 14700-14705.
115. Stoick-Cooper, C. L.; Weidinger, G.; Riehle, K. J.; Hubbert, C.; Major, M. B.; Fausto, N.; Moon, R. T. Distinct Wnt signaling pathways have opposing roles in appendage regeneration. Development 2007, 134, 479-489.
116. Zhu, C.; Chen, Y. L.; Wang, X. J.; Hu, X. S.; Yu, Z. B.; Han, S. P. ShRNA-mediated gene silencing of AHR promotes the differentiation of P19 mouse embryonic carcinoma cells into cardiomyocytes. Mol. Med. Rep. 2012, 6, 513-518.
117. Mikels, A. J.; Nusse, R. Purified Wnt5a Protein Activates or Inhibits β-Catenin-TCF Signaling Depending on Receptor Context. PLoS Biol. 2006, 4, e115.
118. Van Amerongen, R.; Fuerer, C.; Mizutani, M.; Nusse, R. Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development. Dev. Biol. 2012, 369, 101-114.
119. Okamoto, M.; Udagawa, N.; Uehara, S.; Maeda, K.; Yamashita, T.; Nakamichi, Y.; Kato, H.; Saito, N.; Minami, Y.; Takahashi, N.; et al. Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis. Sci. Rep. 2014, 4, 4493.
120. Wu, X.; Daniels, G.; Shapiro, E.; Xu, K.; Huang, H.; Li, Y.; Logan, S.; Greco, M. A.; Peng, Y.; Monaco, M. E.; et al. LEF1 Identifies Androgen-Independent Epithelium in the Developing Prostate. Mol. Endocrinol. 2011, 25, 1018-1026.
121. Francis, J. C.; Thomsen, M. K.; Taketo, M. M.; Swain, A. Β-catenin is required for prostate development and cooperates with pten loss to drive invasive carcinoma. PLoS Genet. 2013, 9, e1003180.
122. Wiese, C.; Rolletschek, A.; Kania, G.; Navarrete-Santos, A.; Anisimov, S. V.; Steinfarz, B.; Tarasov, K. V.; Brugh, S. A.; Zahanich, I.; Ruschenschmidt, C.; et al. Signals from embryonic fibroblasts induce adult intestinal epithelial cells to form nestin-positive cells with proliferation and multilineage differentiation capacity in vitro. Stem Cells 2006, 24, 2085-2097.
123. Bellon, M.; Ko, N. L.; Lee, M. J.; Yao, Y.; Waldmann, T. A.; Trepel, J. B.; Nicot, C. Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood 2013, 121, 5045-5054.
124. Hu, X.; Gao, J. H.; Liao, Y. J.; Tang, S. J.; Lu, F. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin delays palatal shelf elevation and suppresses Wnt5a and lymphoid enhancing-binder factor 1 signaling in developing palate. Cleft Palate-Craniofacial J. 2014, in press.
125. Najdi, R.; Holcombe, R. F.; Waterman, M. L. Wnt signaling and colon carcinogenesis: Beyond APC. J. Carcinog. 2011, 10, doi: 10.4103/1477-3163.78111.
126. min/+ mouse. Cancer Sci. 2007, 98, 6-10.
127. Foley, P. J.; Scheri, R. P.; Smolock, C. J.; Pippin, J.; Green, D. W.; Drebin, J. A. Targeted Suppression of β-Catenin Blocks Intestinal Adenoma Formation in APC Min Mice. J. Gastrointest. Surg. 2008, 12, 1452-1458.
128. V12 mutations. Mol. Cancer 2010, 9, 63.
129. Xu, G.; Zhou, Q.; Wan, C.; Wang, Y.; Liu, J.; Li, Y.; Nie, X.; Cheng, C.; Chen, G. 2, 3, 7, 8-TCDD induces neurotoxicity and neuronal apoptosis in the rat brain cortex and pc12 cell line through the down-regulation of the Wnt/β-catenin signaling pathway. Neurotoxicology 2013, 37, 63-73.
130. Tsang, H.; Cheung, T. Y.; Kodithuwakku, S. P.; Chai, J.; Yeung, W. S.; Wong, C. K.; Lee, K. F. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses spheroids attachment on endometrial epithelial cells through the down-regulation of the Wnt-signaling pathway. Reprod. Toxicol. 2012, 33, 60-66.
131. Zhao, S.; Kanno, Y.; Nakayama, M.; Makimura, M.; Ohara, S.; Inouye, Y. Activation of the aryl hydrocarbon receptor represses mammosphere formation in mcf-7 cells. Cancer Lett. 2012, 317, 192-198.
132. Henry, E. C.; Welle, S. L.; Gasiewicz, T. A. TCDD and a Putative Endogenous AHR Ligand, ITE, Elicit the Same Immediate Changes in Gene Expression in Mouse Lung Fibroblasts. Toxicol. Sci. 2010, 114, 90-100.
133. Pennica, D.; Swanson, T. A.; Welsh, J. W.; Roy, M. A.; Lawrence, D. A.; Lee, J.; Brush, J.; Taneyhill, L. A.; Deuel, B.; Lew, M.; et al. Wisp genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 1998, 95, 14717-14722.
134. Abler, L. L.; Keil, K. P.; Mehta, V.; Joshi, P. S.; Schmitz, C. T.; Vezina, C. M. A high-resolution molecular atlas of the fetal mouse lower urogenital tract. Dev. Dyn. 2011, 240, 2364-2377.
135. Thomson, A. A. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001, 121, 187-195.
136. Marker, P. C.; Donjacour, A. A.; Dahiya, R.; Cunha, G. R. Hormonal, cellular, and molecular control of prostatic development. Dev. Biol. 2003, 253, 165-174.
137. Meeks, J. J.; Schaeffer, E. M. Genetic regulation of prostate development. J. Androl. 2011, 32, 210-217.
138. Lin, T. M.; Rasmussen, N. T.; Moore, R. W.; Albrecht, R. M.; Peterson, R. E. Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of c57bl/6 mice exposed in utero to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2003, 76, 171-181.
139. Timms, B. G. Prostate development: A historical perspective. Differ. Res. Biol. Divers. 2008, 76, 565-577.
140. Cunha, G. R.; Ricke, W.; Thomson, A.; Marker, P. C.; Risbridger, G.; Hayward, S. W.; Wang, Y. Z.; Donjacour, A. A.; Kurita, T. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J. Steroid Biochem. Mol. Biol. 2004, 92, 221-236.
141. Prins, G. S.; Putz, O. Molecular signaling pathways that regulate prostate gland development. Differ. Res. Biol. Divers. 2008, 76, 641-659.
142. Huang, S. M.; Mishina, Y. M.; Liu, S.; Cheung, A.; Stegmeier, F.; Michaud, G. A.; Charlat, O.; Wiellette, E.; Zhang, Y.; Wiessner, S.; et al. Tankyrase inhibition stabilizes axin and antagonizes wnt signalling. Nature 2009, 461, 614-620.
143. Branam, A. M.; Davis, N. M.; Moore, R. W.; Schneider, A. J.; Vezina, C. M.; Peterson, R. E. TCDD inhibition of canonical wnt signaling disrupts prostatic bud formation in mouse urogenital sinus. Toxicol. Sci. 2013, 133, 42-53.
144. Mehta, V.; Schmitz, C. T.; Keil, K. P.; Joshi, P. S.; Abler, L. L.; Lin, T. M.; Taketo, M. M.; Sun, X.; Vezina, C. M. β-catenin (CTNNB1) induces bmp expression in urogenital sinus epithelium and participates in prostatic bud initiation and patterning. Dev. Biol. 2013, 376, 125-135.
145. Mulholland, D. J.; Dedhar, S.; Coetzee, G. A.; Nelson, C. C. Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev. 2005, 26, 898-915.
146. Verras, M.; Sun, Z. Roles and regulation of Wnt signaling and β-catenin in prostate cancer. Cancer Lett. 2006, 237, 22-32.
147. Terry, S.; Yang, X.; Chen, M. W.; Vacherot, F.; Buttyan, R. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. J. Cell. Biochem. 2006, 99, 402-410.
148. Schweizer, L.; Rizzo, C. A.; Spires, T. E.; Platero, J. S.; Wu, Q.; Lin, T. A.; Gottardis, M. M.; Attar, R. M. The androgen receptor can signal through Wnt/β-catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. BMC Cell Biol. 2008, 9, 4.
149. Lin, T. M.; Ko, K.; Moore, R. W.; Simanainen, U.; Oberley, T. D.; Peterson, R. E. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in c57bl/6 mice. Toxicol. Sci. 2002, 68, 479-487.
150. Ko, K.; Moore, R. W.; Peterson, R. E. Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 2004, 196, 149-155.
151. Ko, K.; Theobald, H. M.; Moore, R. W.; Peterson, R. E. Evidence that inhibited prostatic epithelial bud formation in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus. Toxicol. Sci. 2004, 79, 360-369.
152. Schneider, A. J.; Moore, R. W.; Branam, A. M.; Abler, L. L.; Keil, K. P.; Mehta, V.; Vezina, C. M.; Peterson, R. E. In utero exposure to TCDD alters Wnt signaling during mouse prostate development: Linking ventral prostate agenesis to downregulated β-catenin signaling. Toxicol. Sci. 2014, 141, 176-187.
153. Allgeier, S. H.; Lin, T. M.; Vezina, C. M.; Moore, R. W.; Fritz, W. A.; Chiu, S. Y.; Zhang, C.; Peterson, R. E. Wnt5a selectively inhibits mouse ventral prostate development. Dev. Biol. 2008, 324, 10-17.
154. Van der Flier, L. G.; Sabates-Bellver, J.; Oving, I.; Haegebarth, A.; De Palo, M.; Anti, M.; van Gijn, M. E.; Suijkerbuijk, S.; Van de Wetering, M.; Marra, G.; et al. The Intestinal Wnt/TCF Signature. Gastroenterology 2007, 132, 628-632.
155. Chai, R.; Xia, A.; Wang, T.; Jan, T. A.; Hayashi, T.; Bermingham-McDonogh, O.; Cheng, A. G. Dynamic expression of lgr5, a Wnt target gene, in the developing and mature mouse cochlea. J. Assoc. Res. Otolaryngol. 2011, 12, 455-469.
156. Roose, J. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target tcf1. Science 1999, 285, 1923-1926.
157. Zirn, B.; Samans, B.; Wittmann, S.; Pietsch, T.; Leuschner, I.; Graf, N.; Gessler, M. Target genes of the Wnt/β-catenin pathway in wilms tumors. Genes Chromosom. Cancer 2006, 45, 565-574.
158. Ha, A.; Perez-Iratxeta, C.; Liu, H.; Mears, A. J.; Wallace, V. A. Identification of Wnt/β-catenin modulated genes in the developing retina. Mol. Vis. 2012, 18, 645-656.
159. Martinez, G.; Wijesinghe, M.; Turner, K.; Abud, H. E.; Taketo, M. M.; Noda, T.; Robinson, M. L.; de Iongh, R. U. Conditional Mutations of β-Catenin and APC Reveal Roles for Canonical Wnt Signaling in Lens Differentiation. Investig. Ophthalmol. Vis. Sci. 2009, 50, 4794-4806.
160. Vezina, C. M.; Allgeier, S. H.; Moore, R. W.; Lin, T. M.; Bemis, J. C.; Hardin, H. A.; Gasiewicz, T. A.; Peterson, R. E. Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate. Toxicol. Sci. 2008, 106, 488-496.
161. Keil, K. P.; Mehta, V.; Branam, A. M.; Abler, L. L.; Buresh-Stiemke, R. A.; Joshi, P. S.; Schmitz, C. T.; Marker, P. C.; Vezina, C. M. Wnt inhibitory factor 1 (WIF1) is regulated by androgens and enhances androgen-dependent prostate development. Endocrinology 2012, 153, 6091-6103.
162. Hsieh, J. C.; Kodjabachian, L.; Rebbert, M. L.; Rattner, A.; Smallwood, P. M.; Samos, C. H.; Nusse, R.; Dawid, I. B.; Nathans, J. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398, 431-436.
163. Malinauskas, T.; Aricescu, A. R.; Lu, W.; Siebold, C.; Jones, E. Y. Modular mechanism of Wnt signaling inhibition by wnt inhibitory factor 1. Nat. Struct. Mol. Biol. 2011, 18, 886-893.
164. Bányai, L.; Kerekes, K.; Patthy, L. Characterization of a Wnt-binding site of the WIF-domain of Wnt inhibitory factor-1. FEBS Lett. 2012, 586, 3122-3126.
165. Yoon, J. K.; Lee, J. S. Cellular signaling and biological functions of R-spondins. Cell. Signal. 2012, 24, 369-377.
166. Thomson, A. A. Mesenchymal mechanisms in prostate organogenesis. Differ. Res. Biol. Divers. 2008, 76, 587-598.
167. Warner, D. R.; Smith, H. S.; Webb, C. L.; Greene, R. M.; Pisano, M. M. Expression of Wnts in the developing murine secondary palate. Int. J. Dev. Biol. 2009, 53, 1105-1112.
168. Liu, F.; Millar, S. E. Wnt/β-catenin signaling in oral tissue development and disease. J. Dent. Res. 2010, 89, 318-330.
169. Hayano, S.; Kurosaka, H.; Yanagita, T.; Kalus, I.; Milz, F.; Ishihara, Y.; Islam, M. N.; Kawanabe, N.; Saito, M.; Kamioka, H.; et al. Roles of heparan sulfate sulfation in dentinogenesis. J. Biol. Chem. 2012, 287, 12217-12229.
170. Reddy, S.; Andl, T.; Bagasra, A.; Lu, M. M.; Epstein, D. J.; Morrisey, E. E.; Millar, S. E. Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of sonic hedgehog in hair follicle morphogenesis. Mech. Dev. 2001, 107, 69-82.
171. Fu, J.; Hsu, W. Epidermal wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis. J. Investig. Dermatol. 2013, 133, 890-898.
172. Bohring, A.; Stamm, T.; Spaich, C.; Haase, C.; Spree, K.; Hehr, U.; Hoffmann, M.; Ledig, S.; Sel, S.; Wieacker, P.; et al. Wnt10a mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes. Am. J. Hum. Genet. 2009, 85, 97-105.
173. Alaluusua, S.; Lukinmaa, P. L. Developmental dental toxicity of dioxin and related compounds-a review. Int. Dent. J. 2006, 56, 323-331.
174. Panteleyev, A. A.; Bickers, D. R. Dioxin-induced chloracne-Reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp. Dermatol. 2006, 15, 705-730.
175. Loertscher, J. A.; Lin, T. M.; Peterson, R. E.; Allen-Hoffmann, B. L. In utero exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol. Sci. 2002, 68, 465-472.
176. Mazieres, J.; You, L.; He, B.; Xu, Z.; Lee, A. Y.; Mikami, I.; McCormick, F.; Jablons, D. M. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1; 19) translocation induces apoptosis. Oncogene 2005, 24, 5396-5400.
177. Sun, Y.; Campisi, J.; Higano, C.; Beer, T. M.; Porter, P.; Coleman, I.; True, L.; Nelson, P. S. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through Wnt16b. Nat. Med. 2012, 18, 1359-1368.
178. Jiang, Z.; von den Hoff, J. W.; Torensma, R.; Meng, L.; Bian, Z. Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/β-catenin pathway. J. Cell. Physiol. 2014, 229, 384-392.
179. Binet, R.; Ythier, D.; Robles, A. I.; Collado, M.; Larrieu, D.; Fonti, C.; Brambilla, E.; Brambilla, C.; Serrano, M.; Harris, C. C.; et al. Wnt16b is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/Akt pathway. Cancer Res. 2009, 69, 9183-9191.
180. Clements, W. K.; Kim, A. D.; Ong, K. G.; Moore, J. C.; Lawson, N. D.; Traver, D. A somitic Wnt16/notch pathway specifies haematopoietic stem cells. Nature 2011, 474, 220-224.
181. Lu, D.; Zhao, Y.; Tawatao, R.; Cottam, H. B.; Sen, M.; Leoni, L. M.; Kipps, T. J.; Corr, M.; Carson, D. A. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2004, 101, 3118-3123.
182. Nygren, M. K.; Dosen-Dahl, G.; Stubberud, H.; Walchli, S.; Munthe, E.; Rian, E. β-catenin is involved in N-cadherin-dependent adhesion, but not in canonical wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells. Exp. Hematol. 2009, 37, 225-233.
183. Teh, M. T.; Blaydon, D.; Ghali, L. R.; Briggs, V.; Edmunds, S.; Pantazi, E.; Barnes, M. R.; Leigh, I. M.; Kelsell, D. P.; Philpott, M. P. Role for Wnt16b in human epidermal keratinocyte proliferation and differentiation. J. Cell Sci. 2007, 120, 330-339.
184. Anastas, J. N.; Moon, R. T. Wnt signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13, 11-26.
185. Topol, L.; Jiang, X.; Choi, H.; Garrett-Beal, L.; Carolan, P. J.; Yang, Y. Wnt-5a inhibits the canonical wnt pathway by promoting GSK-3-independent β-catenin degradation. J. Cell Biol. 2003, 162, 899-908.
186. Yuzugullu, H.; Benhaj, K.; Ozturk, N.; Senturk, S.; Celik, E.; Toylu, A.; Tasdemir, N.; Yilmaz, M.; Erdal, E.; Akcali, K. C.; et al. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol. Cancer 2009, 8, 90.
187. Li, J.; Ying, J.; Fan, Y.; Wu, L.; Ying, Y.; Chan, A. T. C.; Srivastava, G.; Tao, Q. Wnt5a antagonizes Wnt/β-catenin signaling and is frequently silenced by promoter cpg methylation in esophageal squamous cell carcinoma. Cancer Biol. Ther. 2010, 10, 617-624.
188. Witte, F.; Dokas, J.; Neuendorf, F.; Mundlos, S.; Stricker, S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr. Patterns 2009, 9, 215-223.
189. Huang, L.; Pu, Y.; Hu, W. Y.; Birch, L.; Luccio-Camelo, D.; Yamaguchi, T.; Prins, G. S. The role of Wnt5a in prostate gland development. Dev. Biol. 2009, 328, 188-199.
190. Jönsson, M. E.; Kubota, A.; Timme-Laragy, A. R.; Woodin, B.; Stegeman, J. J. Ahr2-dependence of PCB126 effects on the swim bladder in relation to expression of CYP1 and cox-2 genes in developing zebrafish. Toxicol. Appl. Pharmacol. 2012, 265, 166-174.